Investors
Investor relations
Latest news
Camurus announces expansion of Lilly collaboration
Camurus’ Board of Directors exercises authorization for repurchase of shares for the purpose of securing the company’s commitments under the Performance Share Plan 2026/2029
Resolutions at the annual general meeting 2026 in Camurus
Corporate presentation
-
22Jun
BIO International Convention 2026
Camurus will participate in this conference in San Diego, CA, US, 22-25 June, 2026.
-
15Jul
Interim Report January-June 2026
The interim report January-June is published on 15 July 2026.
-
02Sep
Pareto Securities’ 17th Annual Healthcare Conference
Camurus’ Chief Business Development Officer Fredrik Joabsson is presenting at this conference in Stockholm, 2 September. The presentation can be seen by the conference participants. More information will follow closer to the event.
AGM 2026
Camurus’ Annual General Meeting 2026 was held on 28 May 2026 in Lund, Sweden.
See documents for Annual General Meeting 2026
See more information on Camurus general meetings
Latest financial report
Camurus’ Interim Report January-March 2026
12 May 2026
Annual Report 2025
ESG rankings
Camurus has an ambitious sustainability agenda with the aim of improving the company’s sustainability performance and contribution to the UN’s Sustainable Development Goals. Our performance and progress is regularly evaluated by independent third-party ESG ratings.
Nasdaq Transparency Partner
Since 2022, Camurus is a Nasdaq ESG Transparency Partner. The certification demonstrates Camurus’ commitment to market transparency and raising environmental standards.
Investor contact
IPO and Prospectus
subscribe
Get the latest news from Camurus
Subscribe to receive latest news from Camurus driectly to your email.
